Biogaia are in the news again with two studies that point to the Swedish firm’s Lactobacillus reuteri Protectis probiotic that appear to show promise for managing colic in breastfed infants.
Probiotics International (Protexin) may invest in children’s health research for its seven-strain synbiotic mix Bio-Kult Infantis, following independent research linking it to improvements in baby colic, its medical advisor says.
BioGaia drives niche market for newborns with colic
A study involving 167 breastfed and probiotic formula fed ‘excessive crying’ infants has found no benefits for the formula-fed ones, even though other studies showed probiotics could reduce the malady.
There is not enough evidence to support use of the probiotic Lactobacillus reuteri to manage colic or prevent crying infants, according to a new analysis.
Use of the probiotic Lactobacillus reuteri Protectis could help soothe babies suffering from a common condition known as colic, according to new research.
Probiotic bacteria drops appear to reduce the symptoms of colic in
breast-feeding infants and could offer a natural, more effective
alternative to conventional treatment, say researchers.